Analysts Viewpoint Seres Therapeutics Inc (MCRB) may enjoy gains as insiders got busy in the recent days Seres Therapeutics Inc’s recent filing unveils that its CEO and President Shaff Eric D. unloaded Company’s shares for reported $12473.0
Analysts Viewpoint Analyzing Seres Therapeutics Inc (MCRB) After Recent Trading Activity Seres Therapeutics Inc’s recent filing unveils that its CEO and President Shaff Eric D. unloaded Company’s shares for reported $12473.0
Insiders Updates MCRB (Seres Therapeutics Inc) may reap gains as insiders became active recently Seres Therapeutics Inc’s recently made public that its CEO and President Shaff Eric D. unloaded Company’s shares for reported $12473.0
Insiders Updates Oppenheimer gives an Outperform recommendation for Seres Therapeutics Inc (MCRB) In a filing, Seres Therapeutics Inc revealed its CEO and President Shaff Eric D. unloaded Company’s shares for reported $12473.0